Phase 3 Trial of Single-Dose Intravesical EOquin® as a Surgical Adjuvant for Noninvasive Bladder Cancer

This study is currently recruiting participants.

Study NCT00598806 Information provided by Spectrum Pharmaceuticals, Inc

First Received: January 11, 2008 Last Updated: May 20, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	April 2010
Estimated Primary Completion Date:	April 2010 (Final data collection date for primary outcome measure)